Reduced quality of in-vitro clot formation with gelatin-based plasma substitutes [1]

Lancet

Volumn 347, Issue 9004, 1996, Pages 825-

  Mardel, S N ^a   Saunders, F ^a   Ollerenshaw, L ^a   Edwards, C ^a   Baddeley, D ^a  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN DEGRADATION PRODUCT; FIBRINOGEN; GELATIN; GELATIN SUCCINATE; PLASMA SUBSTITUTE; POLYGELINE;

BLOOD CLOTTING; BLOOD CLOTTING TIME; COLLOID; HEMODILUTION; HUMAN; LETTER; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY;

EID: 0029880106     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)90897-1     Document Type: Letter

References (4)

1. H. Harke R. Thoenies I. Margraf W. Momsen Der Einflub verschiedener Plasmersatzmittel auf Gerinnungssystem und Thrombocytenfunktion wahrend und nach operativen Eingriffen Anaesthetist 25 1976 366
2. J. Stibbe Ep Kirby Letter: Inhibition of ristocetin-induced platelet aggregation by haemaccel BMJ 2 1975 750
3. B. Brodin F. Hesselvik H. von-Schenck Decrease of plasma fibronectin concentration following infusion of a gelatin based plasma substitute in man Scand J Clin Lab Invest 44 1984 529
4. Hw Kim H. Stubdal Ag Greenburg Coagulation dynamics after hemodilution with polyhemoglobin Surg Gynecol Obstet 175 1992 219